IDO1 and Huntington disease: The YAC128 mouse model of HD is known for higher IDO expression and sensitivity to NMDA mediated neurotoxicity and when IDO null mice are challenged with the neurotoxic QA, lesions in the striatum are smaller that suggest neuroprotective effects due to inhibiting neurotoxic metabolite production [220].